Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 21, 2023

BUY
$0.3 - $2.74 $451 - $4,120
1,504 Added 115.78%
2,803 $1,000
Q2 2022

Aug 15, 2022

BUY
$0.3 - $2.74 $46,093 - $420,984
153,644 Added 81.06%
343,183 $70,000
Q4 2021

Feb 14, 2022

BUY
$3.39 - $6.76 $642,537 - $1.28 Million
189,539 New
189,539 $303,000
Q3 2021

Nov 15, 2021

SELL
$2.1 - $5.19 $2,727 - $6,741
-1,299 Closed
0 $0
Q2 2021

Sep 21, 2023

BUY
$4.68 - $7.39 $5,311 - $8,387
1,135 Added 692.07%
1,299 $6,000
Q2 2021

Aug 16, 2021

BUY
$4.68 - $7.39 $6,079 - $9,599
1,299 New
1,299 $6,000
Q1 2021

May 14, 2021

SELL
$6.81 - $10.55 $1,116 - $1,730
-164 Closed
0 $0
Q4 2020

Sep 21, 2023

BUY
$3.33 - $7.18 $546 - $1,177
164 New
164 $1,000
Q4 2020

Feb 16, 2021

SELL
$3.33 - $7.18 $179,100 - $386,169
-53,784 Reduced 99.7%
164 $1,000
Q3 2020

Nov 13, 2020

BUY
$2.74 - $3.62 $15,957 - $21,082
5,824 Added 12.1%
53,948 $178,000
Q2 2020

Aug 14, 2020

SELL
$3.07 - $4.68 $159,259 - $242,779
-51,876 Reduced 51.88%
48,124 $165,000
Q1 2020

May 15, 2020

BUY
$2.28 - $6.6 $80,472 - $232,947
35,295 Added 54.55%
100,000 $370,000
Q4 2019

Feb 13, 2020

BUY
$3.34 - $5.51 $6,686 - $11,031
2,002 Added 3.19%
64,705 $303,000
Q3 2019

Nov 13, 2019

BUY
$2.23 - $4.61 $67,203 - $138,926
30,136 Added 92.54%
62,703 $201,000
Q2 2019

Aug 14, 2019

SELL
$3.59 - $8.37 $19,278 - $44,946
-5,370 Reduced 14.16%
32,567 $134,000
Q1 2019

May 15, 2019

SELL
$7.71 - $11.24 $2.32 Million - $3.38 Million
-300,432 Reduced 88.79%
37,937 $305,000
Q4 2018

Feb 14, 2019

BUY
$7.3 - $18.3 $2.12 Million - $5.3 Million
289,771 Added 596.26%
338,369 $2.47 Million
Q3 2018

Nov 14, 2018

SELL
$9.77 - $17.15 $1.53 Million - $2.69 Million
-156,749 Reduced 76.33%
48,598 $818,000
Q2 2018

Aug 14, 2018

BUY
$5.43 - $9.83 $1.12 Million - $2.02 Million
205,347 New
205,347 $1.94 Million
Q1 2018

May 15, 2018

SELL
$5.79 - $8.86 $492,150 - $753,100
-85,000 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$5.88 - $9.09 $499,800 - $772,650
85,000
85,000 $659,000

About Endo International plc


  • Ticker ENDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 235,143,008
  • Market Cap $68.8M
  • Description
  • Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocio...
More about ENDP
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.